Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

How our clients use DrugPatentWatch

For drug patent information

— Pharmaceutical business developer, USA

To get the patent status of key drugs

— Marketing manager, Chile

To identify business opportunities and check patent rights

— Managing director pharmaceutical company, Morocco

To get paragraph IV challenges, detailed regulatory status and tentative approvals

— Dosage form R&D services company, India

To get nformation about pending patent expiries in the pharmaceutical market

— Sales, Sweden

Generated: May 26, 2017

DrugPatentWatch Database Preview

Profile for United States of America Patent: 9415009

« Back to Dashboard

US Patent Family Members and Approved Drugs

These international patent data are derived from patent families, based on US drug-patent linkages.
Accordingly, they should not be regarded as comprehensive records of ex-US drug-patent associations.

Glossary
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
9,415,009May 28, 2030
Astrazeneca Pharms
BEVESPI AEROSPHERE
formoterol fumarate; glycopyrrolate
8,324,266May 28, 2030
Astrazeneca Pharms
BEVESPI AEROSPHERE
formoterol fumarate; glycopyrrolate
8,703,806May 28, 2030
Astrazeneca Pharms
BEVESPI AEROSPHERE
formoterol fumarate; glycopyrrolate
8,808,713May 28, 2030
Astrazeneca Pharms
BEVESPI AEROSPHERE
formoterol fumarate; glycopyrrolate
8,815,258Mar 17, 2031
Astrazeneca Pharms
BEVESPI AEROSPHERE
formoterol fumarate; glycopyrrolate
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

How our clients use DrugPatentWatch

To locate providers of active pharmaceutical ingredients and obtain any patent information that may apply

— Organic chemist at a generic drug manufacturer, USA

To obtain a list of all currently off-patent approved small molecule therapeutics or those that will come off patent in the next 5 years

— Licensing / business development, Saudi Arabia

To review IP for certain products that are set to expire shortly

— Senior vice president, pharmaceutical wholesaler, Canada

To do IP due diligence for investment decisions

— Investment manager, South Korea

For information on patented drugs and their generic versions

— Policy analyst, South Africa

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Related Products from thinkBiotech
Links

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot